Linked Life Data

12610743

Source:http://linkedlifedata.com/resource/pubmed/id/12610743

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-2-28
pubmed:abstractText
To assess the effect of chronic hepatic impairment on rosuvastatin disposition, pharmacodynamic activity and tolerability.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0031-6970
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
669-75
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment.
pubmed:affiliation
AstraZeneca, R&D Lund, Experimental Medicine, SE-221 87 Lund, Sweden. steven.simonson@astrazeneca.com
pubmed:publicationType
Journal Article, Clinical Trial